Crossmark

Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis

Crossref DOI link: https://doi.org/10.1016/j.arteri.2023.11.003

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pamporis, Konstantinos

Karakasis, Paschalis

Simantiris, Spyridon

Sagris, Marios

Bougioukas, Konstantinos I.

Fragakis, Nikolaos

Tousoulis, Dimitrios
License Information

Text and Data Mining valid from 2024-03-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis

Journal Title: Clínica e Investigación en Arteriosclerosis

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arteri.2023.11.003

Content Type: article

Copyright: © 2023 Sociedad Española de Arteriosclerosis. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below